Wright State Physicians

Fairborn, Ohio 45324

10 studies enrolling now · 35 studies all time

What they study most

Actinic Keratoses, Actinic Keratosis, Aging, Allergic Contact Dermatitis, Atopic Dermatitis, Bullous Pemphigoid, Chronic Spontaneous Urticaria, Chronic Urticaria, Idiopathic, Discoid Lupus Erythematosus, Eczema, Hidradenitis, Hidradenitis Suppurativa

Studies at this site

• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) — Recruiting now
• A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis — Recruiting now
• DNA Repair Activity in the Skin of Day and Night Shift Workers — Recruiting now
• The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population — Recruiting now
• Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis — Recruiting now
• Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea — Recruiting now
• Gene Expression Changes In Young and Geriatric Skin — Recruiting now
• Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects — Recruiting now
• The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy — Recruiting now
• A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Enrolling by invitation
• A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis — Stopped early
• A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis — Running, not enrolling
• Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus — Stopped early
• A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria — Running, not enrolling
• A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid — Stopped early
• Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa — Stopped early
• Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis — Completed
• A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis — Completed
• Evaluation of Implantable Tibial Neuromodulation Pivotal Study (TITAN 2) — Completed
• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period — Completed
• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2) — Completed
• The Validation of New Photographic Technology for Assessing Skin Lesions — Completed
• Photodynamic Therapy-Induced Immune Modulation: Part III — Stopped early
• Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis — Completed
• Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy — Completed
• Defining N-Acetyl Cysteine as a Treatment for Inhibiting Prurogenic Stimuli — Completed
• Efficacy of Baricitinib In Treatment of Delayed-Type Hypersensitivity Versus Irritant Skin Reactions in Healthy Adult Male Subjects — Completed
• Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis — Stopped early
• Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT) — Completed
• A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS) — Stopped early
• Pilot Studies Testing Levels of P63 in Psoriasis Skin Lesions — Completed
• UVB-Induced MVP Release in Human Skin — Completed
• Photodynamic Therapy and Microvesicles — Withdrawn before enrolling
• InterStim Basic Evaluation Lead Post-Market Clinical Follow-up Study — Completed
• A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp — Completed